Patents by Inventor David Norman Frick

David Norman Frick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV helicase inhibitors and methods of use thereof
    Patent number: 9464064
    Abstract: The present invention discloses thioflavine S and primuline derivatives which inhibit hepatitis C virus helicase and protease activity. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are useful as antiviral agents. The present invention further relates to pharmaceutical compositions containing the aforementioned compounds and methods of treating an HCV infection.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: October 11, 2016
    Assignees: University of Kansas, UWM Research Foundation, Inc.
    Inventors: Jeffrey Aube, Brian Scott Jonathan Blagg, Kevin John Frankowski, David Norman Frick, Kelin Li, Frank John Schoenen
  • HCV Helicase Inhibitors and Methods of Use Thereof
    Publication number: 20140227225
    Abstract: The present invention discloses thioflavine S and primuline derivatives which inhibit hepatitis C virus helicase and protease activity. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are useful as antiviral agents. The present invention further relates to pharmaceutical compositions containing the aforementioned compounds and methods of treating an HCV infection.
    Type: Application
    Filed: September 7, 2012
    Publication date: August 14, 2014
    Applicants: UWM RESEARCH FOUNDATION, INC., UNIVERSITY OF KANSAS
    Inventors: Jeffrey Aube, Brian Scott Jonathan Blagg, Kevin John Frankowski, David Norman Frick, Kelin Li, Frank John Schoenen